Peroxisome proliferator-activated receptor-alpha(-/-) mice show enhanced hepatocyte proliferation in response to the hepatomitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene, a ligand of constitutive androstane receptor

Previously, we have suggested that liver cell proliferation induced by cert ain mitogens is dependent on their binding and activation of nuclear recept ors of the steroid/thyroid superfamily. More recently, it was shown that ab sence of the nuclear receptors peroxisome proliferator-activated receptor-a lpha (PPAR alpha) and constitutive androstane receptor (CAR) completely abo lishes the proliferative response of hepatocytes to the mitogenic stimulus exerted by their specific ligands, peroxisome proliferators (PPs) and 1,4-b is[2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP), respectively. Here we sho w that deletion of the PPAR alpha gene accelerates and enhances the prolife rative response evoked by the xenobiotic 1,4-bis[2-(3,5-dichloropyridyloxy) ] benzene (TCPOBOP), a powerful mouse-liver mitogen and a ligand of the nuc lear receptor CAR. Indeed, the number of hepatocytes entering S phase 24 ho urs after mitogen treatment was much greater in PPAR alpha (-/-) mice compa red with that of wild type mice (labeling indices 21.4% and 7.5%, respectiv ely). Labeling index of hepatocytes from PPAR alpha (-/-) mice was found to be higher than that of wild type mice up to 36 hours after treatment, indi cating that lack of PPAR alpha not only accelerated but also enhanced the o verall proliferative response of the liver. The accelerated entry into S ph ase observed in hepatocytes from PPAR alpha (-/-) mice was associated with a very rapid induction of cyclin D1. No major differences between TCPOBOP-t reated PPAR alpha (-/-) and wild type mice were observed in the expression of the 2 inhibitors of cyclin/CDKs complexes, p27 and p21. The results sugg est that PPAR alpha may play a role in modulating CAR-signaling pathways in the cell, in particular those leading to hepatocyte proliferation.